Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer

SABR波动模型 医学 人口 前列腺癌 放射治疗 癌症 离格 乳腺癌 肺癌 队列 肿瘤科 内科学 外科 波动性(金融) 随机波动 环境卫生 金融经济学 经济
作者
Robert Olson,Will Jiang,Mitchell Liu,Alanah Bergman,Devin Schellenberg,Benjamin Mou,Abraham Alexander,Hannah Carolan,Fred Hsu,Stacy Miller,Siavash Atrchian,Elisa Chan,Clement Ho,Islam Mohamed,Angela Lin,Tanya Berrang,Andrew Bang,Nick Chng,Quinn Matthews,Sarah Baker
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:8 (11): 1644-1644 被引量:50
标识
DOI:10.1001/jamaoncol.2022.4394
摘要

After the publication of the landmark SABR-COMET trial, concerns arose regarding high-grade toxic effects of treatment with stereotactic ablative body radiotherapy (SABR) for oligometastases.To document toxic effects of treatment with SABR in a large cohort from a population-based, provincial cancer program.From November 2016 to July 2020, 381 patients across all 6 cancer centers in British Columbia were treated in this single-arm, phase 2 trial of treatment with SABR for patients with oligometastatic or oligoprogressive disease. During this period, patients were only eligible to receive treatment with SABR in these settings in trials within British Columbia; therefore, this analysis is population based, with resultant minimal selection bias compared with previously published SABR series.Stereotactic ablative body radiotherapy to up to 5 metastases.Rate of grade 2, 3, 4, and 5 toxic effects associated with SABR.Among 381 participants (122 women [32%]), the mean (SD; range) age was 68 (11.1; 30-97) years, and the median (range) follow-up was 25 (1-54) months. The most common histological findings were prostate cancer (123 [32%]), colorectal cancer (63 [17%]), breast cancer (42 [11%]), and lung cancer (33 [9%]). The number of SABR-treated sites were 1 (263 [69%]), 2 (82 [22%]), and 3 or more (36 [10%]). The most common sites of SABR were lung (188 [34%]), nonspine bone (136 [25%]), spine (85 [16%]), lymph nodes (78 [14%]), liver (29 [5%]), and adrenal (15 [3%]). Rates of grade 2, 3, 4, and 5 toxic effects associated with SABR (based on the highest-grade toxic effect per patient) were 14.2%; (95% CI, 10.7%-17.7%), 4.2% (95% CI, 2.2%-6.2%), 0%, and 0.3% (95% CI, 0%-0.8%), respectively. The cumulative incidence of grade 2 or higher toxic effects associated with SABR at year 2 by Kaplan-Meier analysis was 8%, and for grade 3 or higher, 4%.This single-arm, phase 2 clinical trial found that the incidence of grade 3 or higher SABR toxic effects in this population-based study was less than 5%. Furthermore, the rates of grade 2 or higher toxic effects (18.6%) were lower than previously published for SABR-COMET (29%). These results suggest that SABR treatment for oligometastases has acceptable rates of toxic effects and potentially support further enrollment in randomized phase 3 clinical trials.ClinicalTrials.gov Identifier: NCT02933242.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郭子发布了新的文献求助10
1秒前
深情安青的应助被开心德地采纳,获得20
2秒前
2秒前
12111发布了新的文献求助10
3秒前
Nole的应助被独特手机采纳,获得30
3秒前
4秒前
WS发布了新的文献求助10
4秒前
吃的发布了新的文献求助10
4秒前
4秒前
CaliU发布了新的文献求助10
4秒前
诚心八宝粥完成签到,获得积分10
6秒前
安吉吉完成签到,获得积分10
6秒前
7秒前
7秒前
cxy完成签到,获得积分10
7秒前
bushiCC完成签到,获得积分20
7秒前
liche发布了新的文献求助10
8秒前
星辰大海的应助被认真仙人掌采纳,获得10
8秒前
9秒前
海哥哥发布了新的文献求助10
10秒前
10秒前
长大佳完成签到,获得积分10
11秒前
辞旧完成签到,获得积分10
11秒前
11秒前
wanci的应助被pajamsleep采纳,获得10
13秒前
dit发布了新的文献求助10
14秒前
源源完成签到,获得积分10
14秒前
jin完成签到,获得积分10
14秒前
wanci的应助被笑点低小鸭子采纳,获得10
15秒前
15秒前
藏锋守拙123完成签到,获得积分10
15秒前
Jun的应助被科研通管家采纳,获得10
15秒前
香蕉觅云的应助被科研通管家采纳,获得10
15秒前
秋风的应助被科研通管家采纳,获得10
15秒前
斯文败类的应助被科研通管家采纳,获得10
15秒前
在水一方的应助被科研通管家采纳,获得20
16秒前
bkagyin的应助被科研通管家采纳,获得10
16秒前
无极微光的应助被科研通管家采纳,获得20
16秒前
FashionBoy的应助被科研通管家采纳,获得10
16秒前
秋风的应助被科研通管家采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188634
求助须知:如何正确求助?哪些是违规求助? 9576342
关于积分的说明 21847026
捐赠科研通 7786653
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360